Close
Nordic 9Nordic 9

Mike Watson (investor - Angel Investor)

United Kingdom
See something wrong or missing? Let us know
Offices:London

Mike Watson is known as ex-president of Moderna’s infectious disease spinout, and now CEO at Mevox Ltd in the UK.

Average round investment:947k USD
Average number per year:1.0
Distribution: 2021 (1)
Portfolio companies: United Kingdom Baseimmune
Mostly invests in: United Kingdom United Kingdom (1) Health services (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Mike Watson

Name Criteria
United Kingdom GM&C Life Science Fund
83%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Norway Per Otto Wold
80%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Health services, Manufacturing, Software Services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Iceland Sigþór Sigmarsson
80%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Health services, Pharma, Software Services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Sweden Uppsala University Holding
80%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Health services, Manufacturing, Pharma, Software Services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
France Happy Capital
80%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Health services, Manufacturing, Software Services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Sweden Annika Pärson
80%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Health services, Manufacturing, Software Services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
France Visiomed
80%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Health services, Manufacturing, Software Services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Sweden Robin Ramm-Ericson
80%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Health services, Manufacturing, Software Services
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Sweden Västkusten Affärsänglar
80%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Health services, Manufacturing, Pharma, Software Services
  • Similar business models: B2B
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
United States Kelly Ford
80%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Health services, Manufacturing, Software Services
  • Similar business models: B2B
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
Top